Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to $3.9 million.

  • Silo Pharma's Cash & Equivalents fell 1940.52% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 1940.52%. This contributed to the annual value of $3.9 million for FY2024, which is 1082.46% up from last year.
  • Silo Pharma's Cash & Equivalents amounted to $3.9 million in Q3 2025, which was down 1940.52% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Silo Pharma's Cash & Equivalents ranged from a high of $12.3 million in Q3 2022 and a low of $158832.0 during Q2 2023
  • Its 5-year average for Cash & Equivalents is $5.6 million, with a median of $4.5 million in 2024.
  • As far as peak fluctuations go, Silo Pharma's Cash & Equivalents surged by 5061135.29% in 2021, and later crashed by 9836.91% in 2023.
  • Silo Pharma's Cash & Equivalents (Quarter) stood at $9.8 million in 2021, then increased by 15.55% to $11.4 million in 2022, then tumbled by 69.0% to $3.5 million in 2023, then increased by 10.82% to $3.9 million in 2024, then rose by 0.3% to $3.9 million in 2025.
  • Its last three reported values are $3.9 million in Q3 2025, $4.3 million for Q2 2025, and $3.1 million during Q1 2025.